Adrian Hayday | |
|---|---|
Hayday in 2016 | |
| Born | April 1956 (age 69) |
| Alma mater | |
| Awards |
|
| Scientific career | |
| Fields | |
| Institutions | |
| Thesis | Structure and activity of integrated polyoma viral DNA in transformed rat cells (1979) |
| Academic advisors |
|
| Website | |
Adrian Clive Hayday (born April 1956)[3] is a British immunologist who is the Kay Glendinning professor and chair in the Department ofImmunobiology atKing's College London and group leader at theFrancis Crick Institute in the UK.[4][5]
Hayday was educated atQueens' College, Cambridge, where he was awarded a Bachelor of Arts degree innatural sciences (biochemistry) in 1978.[2][1] He went on to complete his PhD inmolecular virology ofPolyomaviridae atImperial College London in 1982.[6]
Hayday began studying immunology as apostdoctoral researcher in 1982 atMassachusetts Institute of Technology (MIT) supervised bySusumu Tonegawa,[2][7] where he identified the molecular basis ofoncogene activation inBurkitt's lymphoma. Thereafter, he first described the genes defininggamma-delta T cells, an evolutionarily conserved yet wholly unanticipated set oflymphocytes. AtYale University,King's College London School of Medicine and theFrancis Crick Institute, Hayday established that gamma-delta T cells are distinct from otherT cells, commonly monitoring body-surface integrity rather than specific infections. Their rapid responses to tissue dysregulation offer protection fromcarcinogenesis, underpinning Hayday's and others' ongoing initiatives to employ the cells forimmunotherapy.[8]
Hayday has received numerous awards, including the William Clyde DeVane Medal, Yale's highest honour for scholarship and teaching. He was elected to head theBritish Society for Immunology (2005–09), and has formally counselledKing's Health Partners, thePasteur Institute,Kyoto University, theMax Planck Institute, the Allen Institute,MedImmune, theNational Institutes of Health, theWellcome Trust, andCancer Research UK whose science committee he chairs.[1] He was elected aFellow of the Royal Society (FRS) in 2016.[1]He is an honorary member of theBritish Society for Immunology.[9]
"All text published under the heading 'Biography' on Fellow profile pages is available underCreative Commons Attribution 4.0 International License." --"Royal Society Terms, conditions and policies". Archived from the original on 25 September 2015. Retrieved9 March 2016.
{{cite web}}: CS1 maint: bot: original URL status unknown (link)
This article about a British scientist is astub. You can help Wikipedia byadding missing information. |